Aralast NP 1 mg Injection
RxNorm 1233711 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Aralast NP 1 mg Injection (RxCUI 1233711). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Takeda Pharmaceuticals America, Inc. 2

Takeda Pharmaceuticals America, Inc.

NDC Product
Plasma Derivative

Aralast Np
NDC 0944-2814

Generic Name
Alpha-1-proteinase Inhibitor (human)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing
NDC Product
Plasma Derivative

Aralast Np
NDC 0944-2815

Generic Name
Alpha-1-proteinase Inhibitor (human)
Dosage Form
Kit
Route
N/A
Marketing
BLA
Active Listing